853
Participants
Start Date
September 30, 2005
Primary Completion Date
May 31, 2019
Study Completion Date
May 31, 2019
Brivaracetam (ucb 34714)
10 mg and 25 mg tablets. Flexible dosing up to 200 mg/day, twice daily. For each subject, the study will last from study entry until either regulatory approval of brivaracetam has been granted by any Health Authority in an indication of adjunctive treatment of partial onset seizures; or until the Sponsor decides to close the study; until a managed access program, named patient program, compassionate use program, or similar type of access program is established as allowed per country-specific requirements in addition to legal and regulatory guidelines, or until the investigational product development is stopped by the Sponsor.
931, Charlottesville
933, Gainesville
935, San Francisco
509, Graz
507, Innsbruck
510, Linz
508, Vienna
501, Edegem
515, Montignies-sur-Sambre
506, Bruges
513, Ghent
974, La Louvière
505, Leuven
951, Vancouver
950, Montreal
952, Québec
545, Beroun
543, Brno
544, Brno
546, České Budějovice
519, Ostrava Trebovice
517, Prague
541, Prague
542, Prague
518, Zlín
900, Helsinki
581, Kuopio
526, Oulu
582, Oulu
527, Seinäjoki
583, Tampere
811, Tampere
633, Lyon
632, Angers
628, Béthune
630, Dijon
624, Lille
625, Marseille
623, Montpellier
635, Nancy
626, Paris
920, Paris
622, Rennes
528, Roanne
823, Saint-Pierre-des-Corps
627, Strasbourg
634, Toulouse
532, Bad Berka
705, Berlin
708, Berlin
536, Bernau
707, Bielefeld
701, Bonn
709, Erlangen
703, Frankfurt
711, Freiburg im Breisgau
537, Göttingen
535, Jena
710, Kehl
531, Liegau-Augustusbad
533, Mainz
560, München
706, München
704, Ulm
649, Hong Kong
650, Shatin
547, Budapest
538, Debrecen
539, Pécs
970, Tel Aviv
830, Bologna
553, Foggia
831, Messina
563, Milan
832, Milan
833, Napoli
554, Pavia
550, Perugia
552, Roma
555, Roma
559, Roma
973, Siena
566, Breda
821, Heemstede
822, Heeze
567, The Hague
571, Fredrikstad
568, Oslo
569, Sandvika
570, Trondheim
575, Bialystok
741, Gdansk
978, Grodzisk Mazowiecki
748, Katowice
976, Katowice
574, Kielce
975, Krakow
744, Lodz
747, Lodz
742, Lublin
977, Poznan
746, Szczecin
573, Warsaw
576, Warsaw
577, Warsaw
743, Warsaw
745, Warsaw
591, Kazan'
578, Moscow
579, Moscow
584, Moscow
586, Moscow
588, Moscow
589, Saint Petersburg
943, Samara
587, Yaroslavl
961, Belgrade
962, Belgrade
657, Singapore
648, George
655, Gwangju
652, Seoul
653, Seoul
654, Seoul
656, Seoul
599, Alcorcón
593, Barcelona
596, Donostia / San Sebastian
594, Madrid
783, Madrid
786, Madrid
595, Vigo
597, Zaragoza
850, Gothenburg
601, Stockholm
604, Umeå
605, Biel
607, Sankt Gallen
606, Tschugg
608, Zurich
671, Taichung
672, Taichung
669, Tainan City
660, Taoyuan District
861, Manouba
860, Tunis
638, Donetsk
637, Kharkiv
641, Kyiv
642, Kyiv
639, Lviv
643, Odesa
640, Uzhhorod
Lead Sponsor
UCB Pharma
INDUSTRY